budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - medicin for obstruktiv sygdomme, - budesonid / formoterol teva pharma b. indikeres kun hos voksne 18 år og ældre. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosuppressiva - se venligst afsnit 4. 1 i resuméet af produktegenskaber i produktinformationsdokumentet.
tomahawk 200 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 200 g/l fluroxypyr
valsartan/hydrochlorthiazid "actavis" 160+12,5 mg filmovertrukne tabletter
actavis group ptc ehf. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+12,5 mg
valsartan/hydrochlorthiazid "actavis" 80+12,5 mg filmovertrukne tabletter
actavis group ptc ehf. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 80+12,5 mg
cleave suspoemulsion
adama northern europe b.v. - florasulam, fluroxypyr - suspoemulsion - 2,5 g/l florasulam ; 100 g/l fluroxypyr
tomahawk 180 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr